http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108743546-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-785 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-785 |
| filingDate | 2018-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-01-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-01-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-108743546-B |
| titleOfInvention | Sevelamer carbonate dry suspension and preparation method thereof |
| abstract | The invention relates to a sevelamer carbonate dry suspension which comprises the following raw material components in parts by weight: 100 parts of sevelamer carbonate, 600 parts of filler 400-containing agent, 50-70 parts of suspending agent and 10-20 parts of flavoring agent. The sevelamer carbonate dry suspension prepared by adopting the formula and the process has the advantages of uniform particle distribution, good stability, good dissolution and good taste; and the blood phosphorus concentration of the patient can be maintained for a long time, the taking times are reduced, and the compliance of the patient is improved. |
| priorityDate | 2018-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 39.